Close Menu

The story has been corrected to say that Vela's ViroKey SARS-CoV-2 RT-PCR Test detects the SARS-CoV-2 ORF1a and RdRp genes, not the N gene, as previously stated.

NEW YORK — Vela Diagnostics and Capstone Healthcare this week received Emergency Use Authorization from the US Food and Drug Administration for their PCR-based SARS-CoV-2 tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.